Insider · CIK 0001304395
Robert J Bitterman
ceochairofficerdirector
Files at PHIO (Phio Pharmaceuticals Corp.). First filing May 23, 2025, latest Sep 23, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
9 / 0
$51k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHIO: Phio Pharmaceuticals Corp.
PHIOOct 9, 2026 · close 0.98
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Phio Pharmaceuticals Corp. | $2,058 2,000 shares | +1% | - | |
| 33Weak | PHIObuy Phio Pharmaceuticals Corp. | $9,900 10,000 shares | +2% | +13% from low-65% from high | |
| 48Moderate | PHIObuy Phio Pharmaceuticals Corp. | $5,150 5,000 shares | +2% | +4% from low-84% from high | |
| 48Moderate | PHIObuy Phio Pharmaceuticals Corp. | $5,100 5,000 shares | +2% | +2% from low-84% from high | |
| 38Weak | PHIObuy Phio Pharmaceuticals Corp. | $5,700 5,000 shares | +2% | +11% from low-83% from high | |
| 33Weak | PHIObuy Phio Pharmaceuticals Corp. | $6,350 5,000 shares | +2% | +26% from low-81% from high | |
| 49Moderate | Phio Pharmaceuticals Corp. | $4,840 2,000 shares | +8% | +145% from low-63% from high | |
| 49Moderate | Phio Pharmaceuticals Corp. | $4,125 1,500 shares | +6% | +176% from low-58% from high | |
| 47Moderate | Phio Pharmaceuticals Corp. | $7,446 4,200 shares | +22% | +77% from low-73% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +400,000 | $0.00 | $0 | 764,871 | 14 d ago |
| Sep 22, 2026 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +2,000 | $1.03 | $2,058 | 364,871 | 20 d ago |
| Sep 11, 2026 | PHIO Phio Pharmaceuticals Corp. | FTax withholding Common Stock, $.0001 par value | -68,550 | $1.03 | $71k | 362,871 | 28 d ago |
| Jun 26, 2026 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +10,000 | $0.99 | $9,900 | 421,421 | Jun 29, 2026 |
| Feb 5, 2026 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +120,000 | $0.00 | $0 | 411,421 | Feb 6, 2026 |
| Dec 31, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.03 | $5,150 | 291,421 | Jan 2, 2026 |
| Dec 23, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.02 | $5,100 | 286,421 | Dec 29, 2025 |
| Nov 21, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.14 | $5,700 | 281,421 | Nov 24, 2025 |
| Nov 18, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.27 | $6,350 | 276,421 | Nov 19, 2025 |
| Sep 11, 2025 | PHIO Phio Pharmaceuticals Corp. | FTax withholding Common Stock, $.0001 par value | -4,111 | $2.32 | $9,538 | 21,421 | Sep 15, 2025 |
| Sep 11, 2025 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +250,000 | $0.00 | $0 | 271,421 | Sep 15, 2025 |
| Jun 10, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $0.0001 par value | +2,000 | $2.42 | $4,840 | 27,149 | Jun 11, 2025 |
| Jun 9, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $0.0001 par value | +1,500 | $2.75 | $4,125 | 25,149 | Jun 10, 2025 |
| May 21, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $0.0001 par value | +3,000 | $1.77 | $5,310 | 22,449 | May 23, 2025 |
| May 22, 2025 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $0.0001 par value | +1,200 | $1.78 | $2,136 | 23,649 | May 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.